#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage I Acute graft versus host disease in intestine Canavan disease Non-small cell lung cancer Acute graft versus host disease in liver Oesophageal carcinoma Glomerulonephritis chronic Stiff person syndrome White matter lesion Neoplasm malignant Anal cancer recurrent Bulbospinal muscular atrophy congenital Thrombotic microangiopathy Non-Hodgkin's lymphoma refractory Angiosarcoma metastatic More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Trials in Disease Gastrointestinal stromal tumour Chondrosarcoma Nephroblastoma – Trials in Disease Hepatic angiosarcoma – Trials in Disease Pemphigoid – Diagnostics Pemphigus – Treatment Haemophagocytic lymphohistiocytosis – Diagnostics Ocular melanoma Osteosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Asp1570 IMA401 Belatacept Copper (64Cu) Chloride Nadroparin Calcium Hydroxypropyl Cellulose Lf Doxorubicin Dextrose Bp Bcmacp03 Anhydrous Caffeine UDONITRECTAG Vonafexor HUMAN COAGULATION FACTOR XIII Bromocriptine Lepidoglyphus Destructor Escitalopram Oxalate Emraclidine Metronidazole Pertuzumab BUDOPRUTUG More therapies…

    Learn about Your Condition

    Pneumothorax Nodal osteoarthritis Congenital pseudarthrosis Dystonia Hypoparathyroidism Orthostatic hypotension Giardiasis Right ventricular dysfunction Retinoblastoma Ovarian granulosa cell tumour Notalgia paraesthetica Small intestine adenocarcinoma VEXAS syndrome Senile dementia Hyperthyroidism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • A study of islatravir and ulonivirine for adults with HIV who have not received previous treatment

    Recruiting

    4 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Islatravir
    • Ulonivirine
    • Emtricitabine
    France Spain

  • A study comparing brelovitug to bulevirtide for treating chronic hepatitis delta infection in patients currently receiving bulevirtide

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatitis D
    Investigated Drugs:
    • Bjt-778
    • Bulevirtide
    Austria Czechia France Germany Italy Romania +1

  • Study of GS-4321 for Healthy People and Patients With Chronic Hepatitis Delta Virus Infection

    Recruiting

    2 1
    Investigated Drugs:
    • GS-4321
    Bulgaria Germany Italy Romania

  • A study on the long-term effectiveness and safety of nine-valent human papillomavirus vaccine in women aged 16 to 26 years for prevention of cervical cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    Denmark Norway Sweden

  • A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

    Recruiting

    3 1
    Investigated Drugs:
    • MOLNUPIRAVIR
    Bulgaria Finland France Germany Italy Poland +2

  • A study testing the safety and effectiveness of inhaled hypochlorous acid in patients with chronic airway infections

    Recruiting

    1 1 1
    Investigated Diseases:
    • Respiratory tract infection
    Investigated Drugs:
    • HYPOCHLOROUS ACID
    Denmark
Previous Page
1 2 3 4 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!